Loading...
Tandem Diabetes Care, Inc.
TNDM•NASDAQ
Healthcare
Medical - Devices
$15.89
$0.45(2.91%)
Tandem Diabetes Care, Inc. (TNDM) Financial Performance & Income Statement Overview
Review Tandem Diabetes Care, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
25.74%
↑ 25.74%
Operating Income Growth
57.50%
↑ 57.50%
Net Income Growth
56.86%
↑ 56.86%
Operating Cash Flow Growth
176.16%
↑ 176.16%
Operating Margin
-16.18%
↓ 16.18%
Gross Margin
46.57%
↑ 46.57%
Net Profit Margin
-16.68%
↓ 16.68%
ROE
-82.64%
↓ 82.64%
ROIC
-28.13%
↓ 28.13%
Tandem Diabetes Care, Inc. (TNDM) Income Statement & Financial Overview
Review Tandem Diabetes Care, Inc.'s (TNDM) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $282.65M | $363.29M | $221.91M | $191.67M |
| Cost of Revenue | $125.19M | $238.64M | $109.12M | $97.002M |
| Gross Profit | $157.46M | $124.65M | $112.79M | $94.67M |
| Gross Profit Ratio | $0.56 | $0.34 | $0.51 | $0.49 |
| R&D Expenses | $52.20M | $51.11M | $49.33M | $46.24M |
| SG&A Expenses | $105.84M | $99.64M | $94.24M | $90.11M |
| Operating Expenses | $158.04M | $150.75M | $143.57M | $136.35M |
| Total Costs & Expenses | $283.23M | $389.38M | $252.68M | $233.35M |
| Interest Income | $4.51M | $5.34M | $2.82M | $5.31M |
| Interest Expense | $1.86M | $1.86M | $1.79M | $1.15M |
| Depreciation & Amortization | $4.25M | $4.21M | $4.11M | $4.04M |
| EBITDA | $4.21M | -$16.54M | -$23.84M | -$33.59M |
| EBITDA Ratio | $0.01 | -$0.05 | -$0.11 | -$0.18 |
| Operating Income | -$582000.00 | -$26.09M | -$30.77M | -$41.68M |
| Operating Income Ratio | -$0.002 | -$0.07 | -$0.14 | -$0.22 |
| Other Income/Expenses (Net) | $598000.00 | $3.48M | $1.03M | $2.15M |
| Income Before Tax | $16000.00 | -$22.61M | -$29.74M | -$39.53M |
| Income Before Tax Ratio | $0.00 | -$0.06 | -$0.13 | -$0.21 |
| Income Tax Expense | -$739000.00 | $637000.00 | $1.07M | $3.19M |
| Net Income | $755000.00 | -$23.25M | -$30.81M | -$42.72M |
| Net Income Ratio | $0.003 | -$0.06 | -$0.14 | -$0.22 |
| EPS | $0.01 | -$0.35 | -$0.47 | -$0.65 |
| Diluted EPS | $0.01 | -$0.35 | -$0.47 | -$0.65 |
| Weighted Avg Shares Outstanding | $65.94M | $65.54M | $64.99M | $65.33M |
| Weighted Avg Shares Outstanding (Diluted) | $66.16M | $65.54M | $64.99M | $65.33M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan